Moberg Pharma AB (publ) (STO:MOB)
Sweden · Delayed Price · Currency is SEK 11.36
+0.24 (2.16%)
Sep 4, 2026, 5:29 PM CET
Moberg Pharma AB Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 212.43 | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 |
Cash & Short-Term Investments | 212.43 | 230.95 | 293.29 | 60.56 | 125.55 | 102.66 |
Cash Growth | -16.61% | -21.25% | 384.33% | -51.77% | 22.30% | 432.28% |
Accounts Receivable | 10.19 | 2.33 | 0.17 | - | 0.38 | 0.47 |
Other Receivables | - | 0.37 | 0.64 | 0.79 | 1.06 | 0.66 |
Receivables | 10.19 | 2.7 | 0.8 | 0.79 | 1.44 | 1.14 |
Inventory | 3.79 | 3.58 | 4.3 | 7.12 | - | - |
Prepaid Expenses | - | 0.62 | 1.58 | 0.9 | 0.72 | 0.75 |
Other Current Assets | - | 0.06 | 0.14 | 0.14 | 0.06 | 0.12 |
Total Current Assets | 226.41 | 237.91 | 300.11 | 69.49 | 127.76 | 104.66 |
Property, Plant & Equipment | 2.01 | 2.81 | 4.42 | 4.94 | 5.98 | 4.52 |
Long-Term Deferred Tax Assets | 93.09 | 92.58 | 95.78 | 28.08 | 22.58 | 14.67 |
Long-Term Deferred Charges | 359.88 | 348.96 | 305.77 | 532.22 | 408.1 | 327.04 |
Total Assets | 681.39 | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | - | 2.93 | 4.16 | 6.77 | 17.11 | 5.31 |
Accrued Expenses | - | 11.19 | 10.67 | 12.5 | 7.56 | 7.45 |
Current Portion of Leases | 1.72 | 1.68 | 1.6 | 1.27 | 2.12 | 2.7 |
Other Current Liabilities | 16.76 | 0.38 | 0.29 | - | - | 0.09 |
Total Current Liabilities | 18.48 | 16.17 | 16.72 | 20.54 | 26.79 | 15.54 |
Long-Term Leases | - | 0.87 | 2.55 | 3.47 | 3.99 | 1.24 |
Other Long-Term Liabilities | - | - | - | - | 0.07 | 0.07 |
Total Liabilities | 18.48 | 17.04 | 19.27 | 24.01 | 30.84 | 16.84 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 47.18 | 47 | 46.69 | 27.96 | 9.83 | 4.41 |
Additional Paid-In Capital | 1,241 | 1,239 | 1,234 | 921.3 | 841.2 | 731.38 |
Retained Earnings | -625.42 | -620.88 | -593.64 | -338.53 | -317.44 | -301.73 |
Total Common Equity | 662.92 | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Shareholders' Equity | 662.92 | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Total Liabilities & Equity | 681.39 | 682.26 | 706.09 | 634.73 | 564.42 | 450.89 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 1.72 | 2.55 | 4.14 | 4.74 | 6.11 | 3.93 |
Net Cash (Debt) | 210.71 | 228.4 | 289.15 | 55.82 | 119.45 | 98.72 |
Net Cash Growth | -16.18% | -21.01% | 418.02% | -53.27% | 20.99% | 730.24% |
Net Cash Per Share | 4.48 | 4.88 | 7.64 | 3.52 | 15.74 | 22.94 |
Filing Date Shares Outstanding | 47.18 | 47 | 46.69 | 27.96 | 9.83 | 4.4 |
Total Common Shares Outstanding | 47.18 | 47 | 46.69 | 27.96 | 9.83 | 4.4 |
Working Capital | 207.93 | 221.74 | 283.39 | 48.95 | 100.97 | 89.12 |
Book Value Per Share | 14.05 | 14.15 | 14.71 | 21.84 | 54.30 | 98.54 |
Tangible Book Value | 662.92 | 665.22 | 686.82 | 610.73 | 533.58 | 434.05 |
Tangible Book Value Per Share | 14.05 | 14.15 | 14.71 | 21.84 | 54.30 | 98.54 |